These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38529867)

  • 1. [Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia].
    Kornetova EG; Galkin SA; Mednova IA; Tsiguntsev VV; Boiko AS; Kornetov AN; Ivanova SA; Bokhan NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):82-87. PubMed ID: 38529867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between components of metabolic syndrome and cognition in patients with schizophrenia.
    Goughari AS; Mazhari S; Pourrahimi AM; Sadeghi MM; Nakhaee N
    J Psychiatr Pract; 2015 May; 21(3):190-7. PubMed ID: 25955261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the Brief Assessment of Cognition in Schizophrenia (BACS) to assess cognitive impairment in older patients with schizophrenia and bipolar disorder.
    Cholet J; Sauvaget A; Vanelle JM; Hommet C; Mondon K; Mamet JP; Camus V
    Bipolar Disord; 2014 May; 16(3):326-36. PubMed ID: 24383665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between visual dysfunction and cognitive deficit in schizophrenia].
    Karpinkaia VY; Tumova MA; Yanushko MG; Sosin DN; Maksimova AA; Ivanov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):61-66. PubMed ID: 34481437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.
    Hagi K; Nosaka T; Dickinson D; Lindenmayer JP; Lee J; Friedman J; Boyer L; Han M; Abdul-Rashid NA; Correll CU
    JAMA Psychiatry; 2021 May; 78(5):510-518. PubMed ID: 33656533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.
    Keefe RS; Poe M; Walker TM; Harvey PD
    J Clin Exp Neuropsychol; 2006 Feb; 28(2):260-9. PubMed ID: 16484097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between metabolic syndrome and cognition in patients with schizophrenia.
    Lindenmayer JP; Khan A; Kaushik S; Thanju A; Praveen R; Hoffman L; Cherath L; Valdez G; Wance D
    Schizophr Res; 2012 Dec; 142(1-3):171-6. PubMed ID: 23106932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.
    Boyer L; Richieri R; Dassa D; Boucekine M; Fernandez J; Vaillant F; Padovani R; Auquier P; Lancon C
    Psychiatry Res; 2013 Dec; 210(2):381-6. PubMed ID: 23850204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
    Réthelyi JM; Czobor P; Polgár P; Mersich B; Bálint S; Jekkel E; Magyar K; Mészáros A; Fábián A; Bitter I
    Eur Arch Psychiatry Clin Neurosci; 2012 Mar; 262(2):107-15. PubMed ID: 21792534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and cognitive deficits in the Greek cohort of Epirus Health Study.
    Koutsonida M; Koskeridis F; Markozannes G; Kanellopoulou A; Mousas A; Ntotsikas E; Ioannidis P; Aretouli E; Tsilidis KK
    Neurol Sci; 2023 Oct; 44(10):3523-3533. PubMed ID: 37162663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
    Purdon SE; Malla A; Labelle A; Lit W
    J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes.
    Gatto NM; Henderson VW; St John JA; McCleary C; Hodis HN; Mack WJ
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2008 Sep; 15(5):627-41. PubMed ID: 18608045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes is associated with lower global cognitive function in schizophrenia.
    Takayanagi Y; Cascella NG; Sawa A; Eaton WW
    Schizophr Res; 2012 Dec; 142(1-3):183-7. PubMed ID: 23031192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and cortisol levels in first-episode schizophrenia patients.
    Havelka D; Prikrylova-Kucerova H; Prikryl R; Ceskova E
    Stress; 2016 Jul; 19(4):383-9. PubMed ID: 27320489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.